Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$334K Hold
1,252
﹤0.01% 298
2025
Q4
$345K Buy
1,252
+4
+0.3% +$1.12K ﹤0.01% 301
2025
Q3
$360K Hold
1,248
﹤0.01% 299
2025
Q2
$413K Hold
1,248
﹤0.01% 296
2025
Q1
$411K Sell
1,248
-28
-2% -$8.44K ﹤0.01% 295
2024
Q4
$352K Hold
1,276
﹤0.01% 302
2024
Q3
$442K Sell
1,276
-4
-0.3% -$1.38K ﹤0.01% 292
2024
Q2
$423K Sell
1,280
-150
-10% -$51.7K ﹤0.01% 294
2024
Q1
$519K Sell
1,430
-109
-7% -$35.9K ﹤0.01% 283
2023
Q4
$461K Sell
1,539
-14
-0.9% -$4.09K ﹤0.01% 286
2023
Q3
$444K Buy
1,553
+6
+0.4% +$1.71K ﹤0.01% 281
2023
Q2
$434K Sell
1,547
-2
-0.1% -$521 ﹤0.01% 292
2023
Q1
$396K Sell
1,549
-159
-9% -$46.3K ﹤0.01% 296
2022
Q4
$566K Sell
1,708
-80
-4% -$25.3K ﹤0.01% 273
2022
Q3
$496K Hold
1,788
﹤0.01% 274
2022
Q2
$471K Buy
1,788
+42
+2% +$10.8K ﹤0.01% 283
2022
Q1
$418K Buy
1,746
+180
+11% +$42.1K ﹤0.01% 294
2021
Q4
$360K Hold
1,566
﹤0.01% 301
2021
Q3
$313K Hold
1,566
﹤0.01% 308
2021
Q2
$371K Hold
1,566
﹤0.01% 305
2021
Q1
$379K Buy
1,566
+9
+0.6% +$2.01K ﹤0.01% 306
2020
Q4
$324K Sell
1,557
-157
-9% -$30.8K ﹤0.01% 304
2020
Q3
$290K Hold
1,714
﹤0.01% 303
2020
Q2
$322K Sell
1,714
-331
-16% -$62.8K ﹤0.01% 303
2020
Q1
$362K Sell
2,045
-75
-4% -$14.5K ﹤0.01% 300
2019
Q4
$434K Sell
2,120
-316
-13% -$57.9K ﹤0.01% 310
2019
Q3
$370K Sell
2,436
-683
-22% -$111K ﹤0.01% 318
2019
Q2
$491K Sell
3,119
-94
-3% -$14.7K ﹤0.01% 305
2019
Q1
$517K Hold
3,213
﹤0.01% 298
2018
Q4
$610K Buy
+3,213
New +$670K 0.01% 284

Other funds holding CI

Bahl & Gaynor's CI Position: Q1 2026 in Review

Bahl & Gaynor held its Cigna (CI) position steady in Q1 2026 at 1,252 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #298.

Bahl & Gaynor first reported a position in CI in Q4 2018 and has held it in 30 quarters since. The position peaked at $610K in Q4 2018. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Bahl & Gaynor held 1,252 shares of Cigna worth $334K as of Q1 2026.
  • Bahl & Gaynor left its Cigna share count unchanged in Q1 2026.
  • Cigna made up ﹤0.01% of Bahl & Gaynor's portfolio in Q1 2026, its #298 holding.
  • Bahl & Gaynor first reported a position in Cigna in Q4 2018 and has held it in 30 quarters since.
  • Bahl & Gaynor's Cigna position peaked at $610K in Q4 2018.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.